Chen C, Wang Z, Sun Z, Li W, Dimitrov D. Development of an efficient method for selection of stable cell pools for protein expression and surface display with Expi293F cells. Cell Biochem Funct. 2023;41:355-364 pubmed publisher

Harrasser M, Gohil S, Lau H, Della Peruta M, Muczynski V, Patel D, et al. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC. Breast Cancer Res. 2022;24:39 pubmed publisher

Chuang S, Papp H, Kuczmog A, Eells R, Condor Capcha J, Shehadeh L, et al. Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19. Pharmaceuticals (Basel). 2022;15: pubmed publisher

Zhang M, Wang X, Hu L, Zhang Y, Zheng H, Wu H, et al. TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein. Microbiol Spectr. 2022;10:e0221221 pubmed publisher

Banta K, Xu X, Chitre A, Au Yeung A, Takahashi C, O Gorman W, et al. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses. Immunity. 2022;55:512-526.e9 pubmed publisher

Konstantoulea K, Guerreiro P, Ramakers M, Louros N, Aubrey L, Houben B, et al. Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure. EMBO J. 2022;41:e108591 pubmed publisher

Chen X, Gentili M, Hacohen N, Regev A. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies. Nat Commun. 2021;12:5506 pubmed publisher

Zhang X, Spiegel J, Martinez Cuesta S, Adhikari S, Balasubramanian S. Chemical profiling of DNA G-quadruplex-interacting proteins in live cells. Nat Chem. 2021;13:626-633 pubmed publisher

Bojadzic D, Alcazar O, Chen J, Chuang S, Condor Capcha J, Shehadeh L, et al. Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect Dis. 2021;7:1519-1534 pubmed publisher

Bojadzic D, Alcazar O, Buchwald P. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Front Pharmacol. 2020;11:600372 pubmed publisher

Chen X, Gentili M, Hacohen N, Regev A. A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies. bioRxiv. 2020;: pubmed publisher

Wang H, Huang P, Hung H, Tseng S, Chang C, Tsai Y, et al. Effect of a Neuropilin-1-Derived Virus Receptor Trap on Enterovirus A71 Infection In Vitro. Antimicrob Agents Chemother. 2020;65: pubmed publisher

Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher

Zhang D, Jiang F, Zaynagetdinov R, Huang H, Sood V, Wang H, et al. Identification and characterization of M6903, an antagonistic anti-TIM-3 monoclonal antibody. Oncoimmunology. 2020;9:1744921 pubmed publisher

Hay C, Ewing L, Hambuchen M, Zintner S, Small J, Bolden C, et al. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse. J Pharmacol Exp Ther. 2020;374:16-23 pubmed publisher

Houben B, Michiels E, Ramakers M, Konstantoulea K, Louros N, Verniers J, et al. Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues. EMBO J. 2020;39:e102864 pubmed publisher

Zhao Y, Li Y, Wu X, Li L, Liu J, Wang Y, et al. Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies. Cancer Biol Ther. 2020;21:72-80 pubmed publisher

Hay C, Gonzalez G, Ewing L, Reichard E, Hambuchen M, Nanaware Kharade N, et al. Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse. PLoS ONE. 2018;13:e0200060 pubmed publisher